Clinical aspects and biological bases of drug-resistant epilepsies

Epilepsy Research

Volumn 34, Issue 2-3, 1999, Pages 109-122

  Regesta, Giovanni ^a   Tanganelli, Paolo ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b PA Micone Hospital   (Italy)

Author keywords

Biological bases; Clinical aspects; Drug resistance; Epilepsy; Genetic factors

Indexed keywords

ANTICONVULSIVE AGENT;

ARTICLE; BRAIN MATURATION; CALCIUM CELL LEVEL; CYTOKINE PRODUCTION; DIAGNOSTIC ERROR; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACTABLE EPILEPSY; KINDLING; NEUROTOXICITY; PRIORITY JOURNAL;

ANTICONVULSANTS; DRUG RESISTANCE; EPILEPSY; FORECASTING; HUMANS;

EID: 0032918385     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00106-5     Document Type: Article

References (131)

1. Aicardi J. Clinical approach to the management of intractable epilepsy. Dev. Med. Child Neurol. 30:1988;429-440.
2. Aicardi J. Epilepsy in brain injured children. Dev. Med. Child Neurol. 32:1990;191-202.
3. Andermann F. Multifactorial inheritance of generalized and focal epilepsy. Anderson W.E., Hauser W.A., Penry J.K., Sing C.F. Genetic Basis of the Epilepsies. 1982;355-374 Raven Press, New York.
4. Andermann F. Brain structure in epilepsy. Shorvon S.D., Fish D.R. et al. Magnetic Resonance Scanning and Epilepsy. 1994;21-27 Plenum Press, New York.
5. Annegers J.F., Hauser W.A., Elveback L.R. Remission of seizures and relapse in patients with epilepsy. Epilepsia. 20:1979;729-737.
6. Annegers U.F., Hauser W.A., Shirts S.B., Kurland L.T. Factors prognostic of unprovoked seizures after febrile convulsions. New Engl. J. Med. 316:1987;493-498.
7. Armstrong D., Rouah E., Zhu Z. et al. The spectrum of histopathology of gangliogliomas in patients with complex partial epilepsy. J. Neuropathol. Exp. Neurol. 47:1988;373.
8. Awas I.A., Rosenfeld J., Hahn J.F., Lüders H. Intractable epilepsy and structural lesions of the brain. Mapping, resection strategies, and seizure outcome. Epilepsia. 32:1991;179-186.
9. Babb T.L. Research on the anatomy and pathology of epileptic tissue. Lüders H. Epilepsy Surgery. 1991;719-727 Raven Press, New York.
10. Becker L.E. Synaptic dysgenesis. Can. J. Neurol. Sci. 18:1991;170-180.
11. Beghi E., Perucca E. The management of epilepsy in the 1990s. Acquisitions, uncertainties and perspectives for future research. Drugs. 49:1995;680-694.
12. Berg A.T., Hauser W.A., Shinnar S. The prognosis of childhood onset epilepsy. Shinnar S., Amir N., Branski D. Childhood Seizures. 1995;93-99 Karger, Basel.
13. Bourgeois B.F.D., Dodson W.E. Antiepileptic and neurotoxic interaction between antiepileptic drugs. Pitlick W.H. Antiepileptic Drugs Interactions. 1989;209-219 Demos Publications, New York.
14. Bruton C.J. The Neuropathology of Temporal Lobe Epilepsy. Mawdsley Monographs. 31:1988;Oxford University Press, Oxford.
15. Camfield P.R., Camfield C.S. Febrile seizures. Shinnar S., Amir N., Bransky D. Childhood Seizures. 1995;32-38 S. Karger, Basel.
16. Camfield P.R., Camfield C.S. Antiepileptic drug therapy: when is epilepsy truly intractable? Epilepsia. 37(Suppl 1):1996;S60-S65.
17. Camfield C.S., Camfield P.R., Gordon K.E., Dooley J.M., Smith B.S. Predicting the outcome of childhood epilepsy - a population based study yelding a simple scoring system. J. Pediatr. 122:1993;861-868.
18. Cascino G.D. Intractable partial epilepsy: evaluation and treatment. Mayo Clin. Proc. 65:1990;1578-1586.
19. Cendes F., Andermann F., Gloor P. et al. Atrophy of mesial structures in patients with temporal lobe epilepsy: cause or consequence of repeated seizures. Ann. Neurol. 34:1994;795-801.
20. Chevrie J.J., Aicardi J. Convulsive disorders in the first year of life: persistence of epileptic seizures. Epilepsia. 20:1979;643-649.
21. Cloyd J.C., Birnbaum A.K., Kriel R.L. Pharmacokinetics in infancy, childhood and adolescence. Wyllie E. The Treatment of Epilepsy. Principles and Practice. 2nd edn:1997;737-746 Williams & Wilkins, Baltimore.
22. Prognosis of epilepsy in newly referred patients: a multicenter prospective study of the effects of monotherapy on the long term course of epilepsy. Epilepsia. 33:1992;45-51.
23. Long-term management of children with fever-associated seizures. Pediatrics. 66:1980;1009-1012.
24. Cordon-Cardo C., O'Brien J.P., Casals D. et al. Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. U.S.A. 86:1989;695-698.
25. Daumas-Duport C., Scheithauer B.V., Chodkiewicz J.P. et al. Dysembryoplastic neuroepitelial tumor: a surgically curable tumor of young patients with intractable partial seizures: report of 39 cases. Neurosurgery. 23:1988;545-556.
26. Dodson W.E., De Lorenzo R.J., Pedley T.A. et al. The treatment of convulsive status epilepticus. J. Am. Med. Assoc. 270:1993;854-859.
27. Duchowny M. Complex partial seizures and predictors of intractability in long-term follow-up. Epilepsia. 34:1987;930-936.
28. Duchowny M. Febrile seizures in childhood. Wyllie E. The Treatment of Epilepsy: Principles and Practice. 1997;622-628 Williams & Wilkins, Baltimore.
29. Elwes R.D.C., Reynolds E.H. The early prognosis of epilepsy. Dam M., Gram L. Comprehensive Epileptology. 1990;715-727 Raven Press, New York.
30. Elwes R.D.C., Johnson A.L., Shorvon S.D., Reynolds E.H. The prognosis for seizure control in newly diagnosed epilepsy. New Engl. J. Med. 311:1984;944-947.
31. Engel J. Jr. Functional exploration of the human epileptic brain and their therapeutic implication. Electroencephalogr. Clin. Neurophysiol. 76:1990;296-316.
32. Engel J. Jr. Recent advances in surgical treatment of temporal lobe epilepsy. Acta Neurol. Scand. 86((Suppl. 5)):1992;71-80.
33. Engel J. Jr. The progressive nature of epilepsy. Am. Acad. Neurol. Annu Courses. 324:1993;1-11.
34. Engel J. Jr., Shewmon D.A. Impact of the kindling phenomenon on clinical epileptology. Morrell F. Kindling and Synaptic Plasticity: the Legacy of Graham Goddard. 1991;195-210 Birkhauser, Boston.
35. Eremberg G., Morris H.H. Febrile seizures. Lüders H., Lesser R.P. Epilepsy: Electroclinical Syndromes. 1987;93-104 Springer-Verlag, London.
36. Falconer N.A., Serafetinides E.A., Corsellis J.A.N. Etiology and pathogenesis of temporal lobe epilepsy. Arch. Neurol. 10:1964;233-248.
37. Feksi A.T., Kaamugisha J., Sander J.W., Gatiti S., Shorvon S.D. Comprehensive primary health care antiepileptic drug treatment in rural and semiurban Kenya. Lancet. 337:1991;406-407.
38. Ferrer I., Pineda M., Tallada M. Abnormal local-circuit neurons in epilepsia partialis continua associated with focal cortical dysplasia. Acta. Neuropathol. (Berlin). 83:1992;647-652.
39. Fish D., Andermann F., Olivier A. Surgical strategies in patients with complex partial seizures and small posterior or extratemporal structural lesions. Neurology. 41:1991;1781-1784.
40. Freeman J.M. Just say no! Drug and febrile seizures. Pediatrics. 86:1990;624.
41. French J.A., Williamson P.D., Thadani M. et al. Characteristics of mesial temporal lobe epilepsy. Results of history and physical examination. Ann. Neurol. 34:1994;774-780.
42. Goodridge D.M.G., Shorvon S.D. Epilepsy in a population of 6000. 1. Demography, diagnosis and classification and the role of hospital services. 2. Treatment and prognosis. Br. Med. J. 287:1983;641-647.
43. Griffin W.S.T., Yeralan O., Sheng J.G. et al. Overexpression of the neurotrophic cytokine S100ß in human temporal lobe epilepsy. J. Neurochem. 65:1995;228-233.
44. Gross-Tsur V., Shinnar S. Convulsive status epilepticus in children. Epilepsia. 34((Suppl.1)):1993;S12-S20.
45. Hakkarainen H. Carbamazepine vs Diphenyl-hydantoin vs their combination in adult epilepsy [Abstr]. Neurology. 30:1980;354.
46. Hauser W.A. Status epilepticus: epidemiologic considerations. Neurology. 40(Suppl.2):1990;9-13.
47. Hauser W.A. The natural history of drug resistant epilepsy: epidemiologic considerations. Epilepsy Res. Suppl. 5:1992;25-28.
48. Heinemann U., Draguhn A., Freker E., Stabel J., Zhang C.L. Strategies for the development of drugs for pharmacoresistant epilepsies. Epilepsia. 35((Suppl 5)):1994;S10-S21.
49. Holowach-Thurston J., Thurston D.L., Hixon B.B., Keller A.J. Prognosis in childhood epilepsy. New Engl. J. Med. 308:1982;831-836.
50. Huttenlocher P.R., Hapke R.J. A follow-up study of intractable seizures in childhood. Ann. Neurol. 28:1990;699-705.
51. Jennet B. Epilepsy After Non-missile Head Injuries. 2nd edition:1975;Heinemann, Chicago.
52. Juul-Jensen P. Epilepsy. A clinical and social analysis of 1,020 adult patients with epileptic seizures. Acta Neurol. Scand. 40(Suppl.5):1964;1-148.
53. Juul-Jensen P. Frequency of recurrence after discontinuance of anticonvulsivant therapy in patients with epileptic seizures. Epilepsia. 5:1964;352-363.
54. Juul-Jensen P. Epidemiology of intractable epilepsy. Schmidt D., Morselli P.L. Intractable Epilepsy: Experimental and Clinical Aspects. 1986;5-11 Raven Press, New York.
55. Kim J.K., Guimaraes P.O., Shen M.Y., Masukawa L.M., Spencer D.D. Hippocampal neuronal density in temporal lobe epilepsy with and without gliomas. Acta. Neuropathol. (Berlin). 80:1990;41-45.
56. Knudsen F.U., Paerrgaard R., Andersen R., Andersen J. Febrile seizures: treatment and outcome. Epilepsia. 36(Suppl.3):1995;216.
57. Leppik I.E. Intractable epilepsy in adults. Theodore W.H. Surgical Treatment of Epilepsy. 1992;7-11 Elsevier, Amsterdam.
58. Levesque M.L., Nakasato N., Vinters H.V., Babb T.L. Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology. J. Neurosurg. 75:1991;364-370.
59. Lindsay J., Ounsted C., Richards P. Long-term outcome in children with temporal lobe seizures. Dev. Med. Child Neurol. 21:1979;285-298.
60. Loiseau P. Intractable epilepsy: prognostic evaluation. Schmidt D., Morselli P.L. Intractable Epilepsy. 1986;227-236 Raven Press, New York.
61. Löscher W. Animal models of intractable epilepsy. Progr. Neurobiol. 53:1997;239-258.
62. Loyning Y., Hauglie-Hanssen E. When should surgery be considered? Johannesen S.I. et al. Intractable Epilepsy. 1995;211-219 Wrightson Biomedical Publishing, Petersfield.
63. Marks D.A., Kim J., Spenser D.D., Spenser S.S. Characteristic of intractable seizure following meningitis and encephalitis. Neurology. 42:1982;1513-1518.
64. Marson A.G., Kadir Z.A., Hutton J.L., Chadwick D.W. The new antiepilepstic drugs: a systematic review of their efficacy and tolerability. Epilepsia. 38:1997;859-880.
65. Mathern G.V., Babb T.L., Vickrey B.G. et al. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain. 118:1995;105-118.
66. Mathern G.W., Pretorius J.K., Babb T.L. Quantified patterns of mossy fibers sprouting and neuron densities in hippocampal and lesional seizures. J. Neurosurg. 82:1995;211-219.
67. Mathern G.W., Babb T.L., Mischel P.S. et al. Childhood generalized and mesial temporal epilepsies demonstrate different amounts and patterns of hippocampal neuron loss and mossy fiber synaptic reorganization. Brain. 119:1996;965-987.
68. Mathern G.W., Leite J.P., Babb T.L. et al. Aberrant hippocampal mossy fiber sprouting correlates with greater NMDAR2 receptor staining. Neuroreport. 7:1996;1029-1035.
69. Matsumoto T., Toni E., Kaba K. et al. Expression of p-glycoprotein in human glioma cell lines and surgical glioma specimens. J. Neurosurg. 74:1991;460-466.
70. Mattia D., Olivier A., Avoli M. Seizure-like discharges recorded in human dysplastic neocortex maintained in vitro. Neurology. 45:1995;1391-1395.
71. Mattson R.H., Cramer J.A., Collins J.F. et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondary generalized tonic-clonic seizures. New Engl. J. Med. 313:1985;145-151.
72. Mattson R.H., Cramer J.A., Collins J.F. Comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. New Engl. J. Med. 327:1992;765-771.
73. Mattson RH. Current challenges in the treatment of epilepsy. Neurology. 44(Suppl 5):1994;S4-S9.
74. Maytal J., Shinnar S., Moshe S.L., Alvarez L.A. Low morbidity and mortality of status epilepticus in children. Pediatrics. 83:1989;323-331.
75. Meencke, H.J., Veith, G., 1992. Migration disturbances in epilepsy. In: Engel, J., Jr., Westerlain, C., et al. (Eds.), Molecular Neurobiology and Epilepsy Epilepsy Research, (Suppl. 9). Elsevier, Amsterdam, pp. 31-40.
76. Morrow C.S., Cowan K.H. Mechanisms and clinical significance of multidrug resistance. Oncology. 2:1988;55-63.
77. Munari C., Tassi L., Kahanem P. et al. Analysis of clinical syntomatology during stereo-EEG recorded mesiotemporal lobe seizures. Wolf P. Epileptic Seizures and Syndromes. 1994;335-357 J. Libbey, London.
78. Nelson K.B., Ellenberg J.H. Prognosis in children with febrile seizures. Pediatrics. 61:1978;720-727.
79. Offringa M., Bossuyt P.M.M., Lubsen J. et al. Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies. J. Pediatr. 124:1994;574-584.
80. Okada R., Moshe S.L., Albala B.J. Infantile status epilepticus and future seizure susceptibility in the rat. Dev. Brain Res. 15:1984;167-183.
81. Okuma T., Kumashiro H. Natural history and prognosis of epilepsy: report of a multi-institutional study in Japan. Epilepsia. 22:1981;35-53.
82. Oller-Daurella L., Pamies R., Oller R. Reduction or discontinuance of antiepileptic drugs in patients seizure free for more than 5 years. Janz D. Epileptology. 1976;218-227 Thieme-Verlag, Stuttgart.
83. Palmini A., Andermann F., Olivier A. et al. Focal neuronal migration disorders and intractable partial epilepsy: a study of 30 patients. Ann. Neurol. 30:1991;741-749.
84. Palmini A., Gambardella A., Andermann F. et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann. Neurol. 37:1995;476-487.
85. Perucca E. Pharmacoresistance. Electroencephalogr. Clin. Neurophysiol. 99(4):1996;388.
86. Reynolds E.H., Shorvon S.D. Monotherapy or polytherapy for epilepsy. Epilepsia. 22:1981;1-10.
87. Reynolds E.H., Elwes R.D.C., Shorvon S.D. Why does epilepsy become intractable? Lancet. ii:1983;952-954.
88. Riordan J.R., Ling V. Genetic and biochemical characterization of multidrug resistance. Pharmacol. Ther. 28:1985;51-75.
89. Robinson M.K., Black A.B., Schapel G.S. Combined gamma-vinylGABA (Vigabatrin) and lamotrigine therapy in management of refractory epilepsy [Abstr]. Epilepsia. 34(suppl 2):1993;109.
90. Rodin E. The Prognosis of Patients with Epilepsy. 1968;C C Thomas, Springfield.
91. Rosman N.P., Labazzo J.L., Colton T. Factors predisposing to afebrile seizures after febrile convulsions and preventive treatment. Ann. Neurol. 34:1993;452.
92. Rowan A.J., Overweg J., Sadikoglu S. et al. Seizure prognosis in long-stay mentally subnormal epileptic patients: interrater EEG and clinical studies. Epilepsia. 21:1980;219-225.
93. Rowan A.J., Meijer S.W., de Beer Pawlikowski N., van der Geest P., Meinardi H. Valproate-ethosuximide combination therapy for refractory absence seizures. Arch. Neurol. 40:1983;797-802.
94. Runge U. Predictors of the course of illness in patients with cryptogenic focal epilepsy with complex partial seizures. J. Epilepsy. 9:1996;176-183.
95. Sagar H.J., Oxbury J.M. Hippocampal neuron loss in temporal lobe epilepsy: correlation with early childhood convulsion. Ann. Neurol. 22:1987;334-340.
96. Salmenperä T., Kälviäinen R. et al. Hippocampal damage caused by seizures in temporal lobe epilepsy. The Lancet. 31:1998;35.
97. Sander J.W.A.S. Some aspects of prognosis in the epilepsies: A review. Epilepsia. 34(6):1993;1007-1016.
98. Satishandra P., Lavine L., Theodore W.H. et al. Risk factors associated with intractable partial seizures. Epilepsia. 28:1987;617.
99. Schachter S.C. Advances in the assessment of refractory epilepsy. Epilepsia. 34(Suppl. 5):1993;S24-S30.
100. Schmidt D., Gram L. Monotherapy versus polytherapy in epilepsy. CNS Drugs. 3:1995;194-208.
101. Schmidt D. Diagnostic and therapeutic management of intractable epilepsy. Schmidt D., Morselli P.L. Intractable Epilepsy: Experimental and Clinical Aspects. 1986;237-257 Raven Press, New York.
102. Shafer S.Q., Hauser W.A., Annengers J.F., Klass D.W. EEG and other early predictors of seizure remission: a community study. Epilepsia. 29:1988;590-600.
103. Shinnar S., Berg A.T. Does antiepileptic drug therapy prevent the development of 'chronic' epilepsy? Epilepsia. 37:1996;701-708.
104. Shinnar S., Vining E.P.G., Mellits E.D. et al. Discontinuing antiepileptic medications in children with epilepsy after two years without seizures: a prospective study. New Engl. J. Med. 313:1985;978-980.
105. Shinnar S., Maytal J., Krasnoff L., Moshe S.L. Recurrent status epilepticus in children. Ann. Neurol. 31:1992;598-604.
106. Shorvon S.D., Reynolds E.H. Early prognosis of epilepsy. Br. Med. J. 285:1982;1699-1701.
107. Shorvon S.D., Reynolds E.H. The nature of epilepsy: evidence from studies of epidemiology, temporal patterns of seizures, prognosis and treatment. Trimble M.R., Reynolds E.H. What is Epilepsy? 1986;36-45 Churchill Livingstone, Edinburgh.
108. Shorvon S.D. The temporal aspects of prognosis in epilepsy. J. Neurol. Neurosurg. Psychiatry. 47:1984;1157-1165.
109. Sillanpää M. Remission of seizures and predictors of intractability in long-term follow-up. Epilepsia. 34:1993;930-936.
110. Sofijanov N.G. Clinical evolution and prognosis of childhood epilepsy. Epilepsia. 23:1982;61-69.
111. Stolarek I., Blaklow J., Thompson G.G. Gamma-vinylGABA (Vigabatrin) and lamotrigine: synergism in refractory epilepsy? Epilepsia. 34(Suppl 2):1993;108-109.
112. Swanson T.H. The pathophysiology of human mesial temporal lobe epilepsy. J. Clin. Neurophysiol. 12:1995;2-22.
113. Tanganelli P., Regesta G. Vigabatrin vs Carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study. Epilepsy Res. 25:1996;257-262.
114. Theodore W.H. What is uncontrolled epilepsy, and who should be referred for surgery? Am. Acad. Neurol. Annu. Sem. 2(272):1993;29-55.
115. Tishler D.M., Weinberg K.I., Hinton D.R. et al. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia. 36:1995;2-6.
116. Todt H. The late prognosis of epilepsy in childhood. Epilepsia. 25:1984;137-144.
117. Towne A.R., Pellock J.M., Ko D., De Lorenzo R.J. Determinants of mortality in status epilepticus. Epilepsia. 35:1994;27-34.
118. Trevathan E., Yearign-Allsop M., Murphy C.C., Ding G. Epilepsy among children with mental retardation. Ann. Neurol. 24:1988;321-325.
119. Ueda K., Cornwell M.M., Gottesman M.M. et al. The MDR1 gene, responsible for multidrug resistance codes for P-glycoprotein. Biochem. Biophys. Res. Commun. 141:1986;956-962.
120. Uvenbrandt P., 1988. Hemiplegic cerebral palsy: aetiology and outcome. Acta. Paediatr. Scand. (Suppl. 77), 6-11.
121. Van Donselaar C.A., Geerts A.T., Schimsheimer R.J. Idiopathic first seizure in adult life: who should be treated. Br. Med. J. 302:1991;620-623.
122. Verity C.M., Golding J. Risk of epilepsy after febrile convulsions: a national cohort study. Br. Med. J. 303:1991;1373-1376.
123. Verity C.M., Ross E.M., Golding J. Outcome of childhood status epilepticus and lengthy febrile convulsions: findings of national cohort study. Br. Med. J. 307:1993;225-228.
124. Vinters H.V., Armstrong D.L., Babb T.L. et al. The neuropathology of human symptomatic epilepsy. Engel J. Jr. Surgical Treatment of Epilepsies. 2nd ed. 1993;593-608 Raven Press, New York.
125. Wada J.A., Osawa T. Spontaneous recurrent seizures state induced by daily electrical amygdaloid stimulation in Senegalese baboons, Papio papio. Neurology. 26:1976;273-286.
126. Walker M.C., Sander J.W.A.S. Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs. Neurology. 46:1996;912-914.
127. White H.S., Kemp J.W., Woodbury D.M. Effect of central nervous system maturation on drug responses. Morselli P.L., Pippenger C.E., Penry J.K. Antiepileptic Drug Therapy in Pediatrics. 1983;13-35 Raven Press, New York.
128. Wieser H.G., Engel J. Jr., Williamson P., Babb T.L., Gloor P. Surgically remediable temporal lobe syndromes. Engel J. Jr. Surgical Treatment of the Epilepsies. 2nd ed. 1993;49-63 Raven Press, New York.
129. Willmore L.J. Post-traumatic epilepsy - mechanisms and prevention. Pedley T.A., Meldrum B.S. Recent Advances in Epilepsy 5. 1992;107-117 Churchill-Livingstone, Edinburgh.
130. Wilmore L.S., Sypert G.W., Munson J.B. Recurrent seizures induced by cortical iron injection. A model of post-traumatic epilepsy. Ann. Neurol. 4:1978;329-336.
131. Wolf S.M., Forsythe A. Epilepsy and mental retardation following febrile seizures in childhood. Acta. Paediatr. Scand. 78:1989;291-295.